全文获取类型
收费全文 | 3210篇 |
免费 | 176篇 |
国内免费 | 25篇 |
专业分类
耳鼻咽喉 | 60篇 |
儿科学 | 70篇 |
妇产科学 | 45篇 |
基础医学 | 405篇 |
口腔科学 | 54篇 |
临床医学 | 357篇 |
内科学 | 500篇 |
皮肤病学 | 68篇 |
神经病学 | 241篇 |
特种医学 | 337篇 |
外科学 | 632篇 |
综合类 | 51篇 |
一般理论 | 1篇 |
预防医学 | 144篇 |
眼科学 | 31篇 |
药学 | 275篇 |
中国医学 | 5篇 |
肿瘤学 | 135篇 |
出版年
2021年 | 28篇 |
2020年 | 26篇 |
2019年 | 45篇 |
2018年 | 45篇 |
2017年 | 28篇 |
2016年 | 54篇 |
2015年 | 65篇 |
2014年 | 81篇 |
2013年 | 118篇 |
2012年 | 158篇 |
2011年 | 161篇 |
2010年 | 94篇 |
2009年 | 82篇 |
2008年 | 146篇 |
2007年 | 141篇 |
2006年 | 123篇 |
2005年 | 109篇 |
2004年 | 94篇 |
2003年 | 129篇 |
2002年 | 125篇 |
2001年 | 93篇 |
2000年 | 118篇 |
1999年 | 104篇 |
1998年 | 83篇 |
1997年 | 66篇 |
1996年 | 37篇 |
1995年 | 33篇 |
1994年 | 34篇 |
1993年 | 32篇 |
1992年 | 46篇 |
1991年 | 35篇 |
1990年 | 48篇 |
1989年 | 68篇 |
1988年 | 53篇 |
1987年 | 54篇 |
1986年 | 53篇 |
1985年 | 54篇 |
1984年 | 35篇 |
1983年 | 36篇 |
1982年 | 31篇 |
1981年 | 22篇 |
1980年 | 25篇 |
1979年 | 24篇 |
1978年 | 30篇 |
1977年 | 25篇 |
1975年 | 28篇 |
1974年 | 20篇 |
1973年 | 34篇 |
1972年 | 29篇 |
1971年 | 24篇 |
排序方式: 共有3411条查询结果,搜索用时 15 毫秒
71.
72.
73.
74.
M. V. Petkova A. Stantzou A. Morin O. Petrova S. Morales-Gonzalez F. Seifert J. Bellec-Dyevre T. Manoliu A. Goyenvalle L. Garcia I. Richard C. Laplace-Builhé M. Schuelke H. Amthor 《Neuropathology and applied neurobiology》2020,46(6):602-614
Background
Dmdmdx, harbouring the c.2983C>T nonsense mutation in Dmd exon 23, is a mouse model for Duchenne muscular dystrophy (DMD), frequently used to test therapies aimed at dystrophin restoration. Current translational research is methodologically hampered by the lack of a reporter mouse model, which would allow direct visualization of dystrophin expression as well as longitudinal in vivo studies.Methods
We generated a DmdEGFP-mdx reporter allele carrying in cis the mdx-23 mutation and a C-terminal EGFP-tag. This mouse model allows direct visualization of spontaneously and therapeutically restored dystrophin-EGFP fusion protein either after natural fibre reversion, or for example, after splice modulation using tricyclo-DNA to skip Dmd exon 23, or after gene editing using AAV-encoded CRISPR/Cas9 for Dmd exon 23 excision.Results
Intravital microscopy in anaesthetized mice allowed live-imaging of sarcolemmal dystrophin-EGFP fusion protein of revertant fibres as well as following therapeutic restoration. Dystrophin-EGFP-fluorescence persisted ex vivo, allowing live-imaging of revertant and therapeutically restored dystrophin in isolated fibres ex vivo. Expression of the shorter dystrophin-EGFP isoforms Dp71 in the brain, Dp260 in the retina, and Dp116 in the peripheral nerve remained unabated by the mdx-23 mutation.Conclusion
Intravital imaging of DmdEGFP-mdx muscle permits novel experimental approaches such as the study of revertant and therapeutically restored dystrophin in vivo and ex vivo.75.
Manuela Mandu-Hrit Manuela Mandu-Hrit Erin Seifert Manuela Mandu-Hrit Erin Seifert Maria Kotsiopriftis 《Growth factors (Chur, Switzerland)》2013,31(3):143-151
We have previously shown that a single injection of rhBMP-7 (OP-1) applied to the regenerate early during distraction accelerates bone consolidation in a rabbit model of distraction osteogenesis. In the present study, we hypothesised that the injection of OP-1 improves bone consolidation by increasing blood flow to the distracted site. Blood flow into the regenerate of a rabbit model was measured and vascular endothelial growth factor (VEGF) expression was tested using semi-quantitative PCR. Immunohistochemistry was used for assessing the temporal and spatial expression of platelet endothelial cell adhesion molecule (PECAM), VEGF and its receptors following OP-1 injection. We observed a higher expression of VEGF and its receptors in the regenerate with OP-1 treatment. However, there was no difference in the increase in bone blood flow nor PECAM expression between the treated and control groups of animals. Interestingly, the increased expression of VEGF and its receptors was associated with chondrocyte and fibroblast-like cells, but not with endothelial cells. These results suggest that accelerated ossification by OP-1 may depend on a non-vascular mechanism, possibly involving a non-angiogenic function of VEGF signalling. 相似文献
76.
77.
78.
79.
Sylvia Baumann Kurer Burkhardt Seifert Beat Michel† Regula Ruegg Jörg Fehr 《British journal of haematology》1995,91(4):820-826
Summary. We prospectively studied 45 anaemic patients (3 7 women, 8 men) with chronic inflammatory rheumatic diseases. The combination of serum ferritin and CRP (as well as ESR) in its predictive capacity for bone marrow iron stores was examined. The relationship between other iron-related measurements (transferrin, transferrin saturation, soluble transferrin receptor, erythrocyte porphyrins and percentage of hypochromic/microcytic erythrocytes) and bone marrow iron stores was also investigated. Stainable bone marrow iron was taken as the most suitable standard to separate iron-deficient from iron-replete patients. 14 patients (31%) were lacking bone marrow iron. Regression analysis showed a good correlation between ferritin and bone marrow iron (adjusted R 2 =0.721, P<00001). The combination of ferritin and CRP (ESR) did not improve the predictive power for bone marrow iron (adjusted R 2 =0.715) in this cohort of patients with low systemic inflammatory activity. With respect to the bone marrow iron content the best predictive cut-off value of ferritin was 30μg/l (86% sensitivity, 90% specificity). The other iron-related parameters both individually and when combined were less powerful in predicting bone marrow iron than ferritin alone. Only zinc bound erythrocyte protoporphyrin in combination with ferritin slightly improved prediction (adjusted R 2 =0.731). A cut-off point of 11% hypochromic erythrocytes reached a high specificity (90%), but was less sensitive (77%). 相似文献
80.
Modulation of in vitro eosinophil progenitors by hydrocortisone: role of accessory cells and interleukins 总被引:1,自引:0,他引:1
The growth of human eosinophil progenitors (CFU-Eo) and the modulation of growth by hydrocortisone were studied as functions of the presence of lymphocytes and monocytes in marrow cells under study; and the source of colony-stimulating factors, specifically, media conditioned by macrophage-like cell line, GCT; phytohemagglutinin-stimulated mononuclear cells (PHA-LCM); or the T cell line, MO. CFU-Eo growth was greatest in marrow containing accessory cells as compared to marrow depleted of accessory cells; and in marrow treated with phytohemagglutinin-stimulated leukocyte conditioned media (PHA-LCM) or MO (T cell line)-conditioned medium (MO-CM) as compared with GCT cell- conditioned medium (GCT-CM). Hydrocortisone reproducibly inhibited eosinophil progenitor growth in unfractionated marrow stimulated by GCT- CM. This effect was abrogated by admixing irradiated mononuclear cells or T lymphocytes with the target marrow or by adding interleukin 1 or interleukin 2 (IL-1, IL-2). Inhibition by hydrocortisone did not occur when monocyte and T lymphocyte depleted marrow was studied. Unlike GCT- CM, MO-CM and PHA-LCM stimulated equal proportions of eosinophil progenitors in nondepleted and accessory cell-depleted marrow and demonstrated less hydrocortisone inhibition. However, both GCT-CM and PHA-LCM produced in the presence of hydrocortisone stimulated significantly fewer CFU-Eos in both unfractionated and accessory cell- depleted marrow target populations. These results indicate that the growth of CFU-Eo and inhibition of growth by hydrocortisone is a direct function of a monocyte-T cell interaction and probably is mediated through effects on the production/release of eosinophil colony stimulating factor (Eo-CSF). 相似文献